Ying Shen

W941, a new PI3K inhibitor, exhibits preferable anti-proliferative activities against nonsmall cell lung cancer with autophagy inhibitors

W. Han, Shu Fan, Man-li Wu, 2019, Investigational New Drugs.

Novel 6-aryl substituted 4-pyrrolidineaminoquinazoline derivatives as potent phosphoinositide 3-kinase delta (PI3Kδ) inhibitors.

Yifan Feng, San-qi Zhang, Shuai Mao, 2018, Bioorganic & medicinal chemistry.

Synthesis and biological activity of new 2,4,6-trisubstituted triazines as potential phosphoinositide 3-kinase inhibitors

San-qi Zhang, Minhang Xin, Hao Zhang, 2020, Journal of Chemical Research.

Discovery of 2,4,6-trisubstitued pyrido[3,4-d]pyrimidine derivatives as new EGFR-TKIs.

Yong-xiao Cao, San-qi Zhang, Yuan-Yuan Hei, 2018, European journal of medicinal chemistry.

Synthesis and evaluation of 2,9-disubstituted 8-phenylthio/phenylsulfinyl-9H-purine as new EGFR inhibitors.

Yan Li, Yong-xiao Cao, San-qi Zhang, 2018, Bioorganic & medicinal chemistry.

Introduction of pyrrolidineoxy or piperidineamino group at the 4-position of quinazoline leading to novel quinazoline-based phosphoinositide 3-kinase delta (PI3Kδ) inhibitors

Yifan Feng, San-qi Zhang, Shuai Mao, 2018, Journal of enzyme inhibition and medicinal chemistry.

Design and synthesis of novel 6-aryl substituted 4-anilinequinazoline derivatives as potential PI3Kδ inhibitors.

San-qi Zhang, Yuan-Yuan Hei, Minhang Xin, 2017, Bioorganic & medicinal chemistry letters.

A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer.

Lei Cao, Yong-xiao Cao, San-qi Zhang, 2019, Anti-cancer drugs.

Discovery of 2-(aminopyrimidin-5-yl)-4-(morpholin-4-yl)-6- substituted triazine as PI3K and BRAF dual inhibitor.

San-qi Zhang, Yuan-Yuan Hei, Minhang Xin, 2018, Future medicinal chemistry.